LONDON-A new study shows that HIV patients are often diagnosed years after their infection, taking away valuable treatment time.
In the United Kingdom, more than one third of HIV patients were diagnosed having a CD4+ cell count of less than 200 cells/µl. This late of a diagnosis puts the patient at an increased risk of infection and limits the chance of successful antiretroviral therapy.
Researchers from the Royal Sussex County Hospital and the Sussex Beacon looked at whether healthcare workers were missing HIV infections when examining patients. After looking at the treatment histories of 49 patients with newly diagnosed HIV from 1997 to 2000, they found 25 patients had been to hospital clinics before being diagnosed. There were five patients who had actually been admitted and treated prior to their diagnosis. Within this group, the average time between the first hospital visit and HIV diagnosis was 995 days. Their mean CD4+ cell count at diagnosis was 76 cells/µl. There were 17 HIV-related deaths in this group between 1997 and 2000, 13 of those patients being in the late diagnosis group.
With these findings, the researchers announced there is an increased need to educate non-HIV specialists about HIV infection. Hospitals and other healthcare organizations should give healthcare workers more information about the virus and how they should test for the disease.
Information from www.hivandhepatitis.com
Together We Rise: Why AORN Expo 2025 Is a Must for Every Perioperative Nurse
March 31st 2025From April 5 to 8, 2025, thousands of perioperative nurses will gather in Boston for the 2025 AORN Global Surgical Conference & Expo—a transformational experience designed to elevate nursing practice, build lifelong connections, and advance surgical care.
Vet IP Roundtable 2: Infection Control and Biosecurity Challenges in Veterinary Care
March 31st 2025Veterinary IPs highlight critical gaps in cleaning protocols, training, and biosecurity, stressing the urgent need for standardized, animal-specific infection prevention practices across diverse care settings.
Invisible, Indispensable: The Vital Role of AHRQ in Infection Prevention
March 25th 2025With health care systems under strain and infection preventionists being laid off nationwide, a little-known federal agency stands as a last line of defense against preventable patient harm. Yet the Agency for Healthcare Research and Quality (AHRQ) is now facing devastating cuts—threatening decades of progress in patient safety.
The Sterile Processing Conference Survival Guide: How to Make the Most of Your Next Event
March 25th 2025From expert speakers to cutting-edge tools, sterile processing conferences, like the 2025 HSPA Annual Conference and the SoCal SPA's Spring Conference, offer unmatched opportunities to grow your skills, expand your network, and strengthen your department's infection prevention game.
Redefining Material Compatibility in Sterilization: Insights From AAMI TIR17:2024
March 24th 2025AAMI TIR17:2024 provides updated, evidence-based guidance on material compatibility with sterilization modalities. It offers essential insights for medical device design and ensures safety without compromising functionality.